Search research articles
Contact Us
Filters
Showing results (881-890 of 987) with videos related to
Page
of 99
Sort By:
Genome Research
|
September 26, 2023
An organism-wide ATAC-seq peak catalog for the bovine and its use to identify regulatory variants
Can Yuan, Lijing Tang, Thomas Lopdell, et al.
Cell Death & Disease
|
June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
Michelle P Clark, Thao Huynh, Shringar Rao, et al.
Virology
|
July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing
Jennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Nature Neuroscience
|
March 31, 2025
A streaming brain-to-voice neuroprosthesis to restore naturalistic communication
Kaylo T Littlejohn, Cheol Jun Cho, Jessie R Liu, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
September 20, 2013
Management of Open Pneumothorax in Tactical Combat Casualty Care: TCCC Guidelines Change 13-02
Frank K Butler, Joseph J DuBose, Edward J Otten, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Nature Cell Biology
|
January 14, 2022
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis
Archita Das, Dipankar Ash, Abdelrahman Y Fouda, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2023
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
Jennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
Journal of Hepatology
|
May 30, 2024
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
Laura C McCoullough, Mohamed Fareh, Wenxin Hu, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Page
of 99
Search research articles
Search
Showing results (881-890 of 987) with videos related to
Sort By:
Page
of 99
Genome Research
|
September 26, 2023
An organism-wide ATAC-seq peak catalog for the bovine and its use to identify regulatory variants
Can Yuan, Lijing Tang, Thomas Lopdell, et al.
Cell Death & Disease
|
June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
Michelle P Clark, Thao Huynh, Shringar Rao, et al.
Virology
|
July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing
Jennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Nature Neuroscience
|
March 31, 2025
A streaming brain-to-voice neuroprosthesis to restore naturalistic communication
Kaylo T Littlejohn, Cheol Jun Cho, Jessie R Liu, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
September 20, 2013
Management of Open Pneumothorax in Tactical Combat Casualty Care: TCCC Guidelines Change 13-02
Frank K Butler, Joseph J DuBose, Edward J Otten, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Nature Cell Biology
|
January 14, 2022
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis
Archita Das, Dipankar Ash, Abdelrahman Y Fouda, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2023
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
Jennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
Journal of Hepatology
|
May 30, 2024
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
Laura C McCoullough, Mohamed Fareh, Wenxin Hu, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Page
of 99